A study by the US National Health Institute showed that a quarter of women in the US suffer from pelvic floor disorders. Worldwide, over a million women suffer from the disorder. This disorder is the inability of the pelvic floor muscles to contract and expand to allow for bowel movement.
In August 2018, Founder and CEO of Renovia Inc., Marc D.Beer, announced the company’s progression for the manufacturing and development of pelvic floor disorder products, aimed at treating it. The pelvic floor is treated through medication, surgery, relaxation techniques and biofeedback which involves re-training of the pelvic muscles. The biofeedback method is the most preferred of them, with a 75% success rate. Renovia’s current product known as the Leva Pelvic Digital Health System, is an FDA cleared pelvic muscle trainer. Making use of visualization techniques. The product was approved in April 2018 by the FDA and it helps patients to target the muscles responsible for lower body self-control and re-train the muscles.
The product allows the patients to do all this and more in the comfort and privacy of their homes. Other features it offers is: proprietary motion sensors, real-time visualization and a tracking system for the patient to keep track of their training sessions.The product comes as a kit comprised of the Pelvic Digital Health System and the EmbaGYN pelvic floor exerciser.
The company, Renovia Inc. states that its main purpose is to boost the orientalism of patients that suffer from pelvic floor disorder. Founded in 2016, the company obtained a huge $32.3 million in funding to continue its research in the pelvic disorder field and to improve their renowned product, Leva. This was achieved through a Series B rounding. Furthermore, the company focuses on providing patients with products that are extensible and consumer friendly in terms of cost. The company, however, does not dabble with all types of pelvic disorders but simply focuses on urinary incontinence.
Renovia Inc. CEO, Marc D. Beer’s exceptional leadership has led the company to its current progressive state. He is an alumnus of the Miami University where he achieved a Bachelor in Science. He also acts as a member of the school advisory council. Furthermore, he serves as part of the advisory committee for the University Notre Dame Research and Commercialization.
Moreover, Mr. Beer served in a number of considerable company boards before the founding of Renovia Inc. in 2016. Some of those companies include privately owned Erytech Pharma,a company in the biopharmaceutical field. The company deals in developing therapies that bring out an innovative standpoint to the unconsidered medical needs in cancer and orphan diseases sector. Learn more: